|
Mar 14
|
Drugmakers agree to participate in second round of price negotiations
|
|
Mar 14
|
The Zacks Analyst Blog Highlights Novo Nordisk, Roche, Pfizer, Arvinas and J&J
|
|
Mar 14
|
Zacks Market Edge Highlights: Tesla, NVIDIA, JPMorgan Chase, Exxon Mobil and Novo Nordisk
|
|
Mar 14
|
An Ozempic successor falls short, Eli Lilly's GLP-1 pill, and senators grill RFK: Pharma news roundup
|
|
Mar 13
|
Novo Nordisk (NVO) Gains As Market Dips: What You Should Know
|
|
Mar 13
|
Is A Recession Coming in 2025? Where to Invest Now
|
|
Mar 13
|
NVO Stock Slips 4% as Roche Inks Obesity Drug Deal With Zealand
|
|
Mar 13
|
Pharma Stock Roundup: RHHBY Obesity Drug Rights Buyout, NVO Pipeline Update
|
|
Mar 13
|
Wall Street's Biggest Novo Nordisk Bear Just Flipped--Here's Why He Says It's Time to Buy
|
|
Mar 13
|
UiPath plunges on weak outlook, Novo Nordisk upgrade: Top Stocks
|
|
Mar 13
|
How to Play VKTX Stock Amid Manufacturing Deal With CordenPharma
|
|
Mar 13
|
Novo Nordisk Skeptic Finally Upgrades Stock After Drop From Peak
|
|
Mar 12
|
Roche Inks 'The Largest Obesity Deal To Date' With Zealand Pharma At $5.3 Billion
|
|
Mar 12
|
Compounded Wegovy and Zepbound may disappear under new FDA rules
|
|
Mar 12
|
Roche, Zealand sign deal: What it means for weight loss drug space
|
|
Mar 12
|
Novo Nordisk Is Falling. Competition Is a Killer.
|
|
Mar 12
|
Novo Nordisk, Starbucks shares slumping: Trending Tickers
|
|
Mar 12
|
iRobot, Target, Novo Nordisk vs. Roche: Market Minute
|
|
Mar 12
|
Why Viking Therapeutics and Roche Holdings Popped Today, but Novo Nordisk Stock Dropped
|
|
Feb 24
|
Here is Why Novo Nordisk A/S (NVO) is Among the Most Oversold Pharma Stocks to Buy According to Analysts
|